Concert: 2Q Earnings Snapshot

August 2, 2018

LEXINGTON, Mass. (AP) _ Concert Pharmaceuticals Inc. (CNCE) on Thursday reported a loss of $13.3 million in its second quarter.

The Lexington, Massachusetts-based company said it had a loss of 57 cents per share.

The biopharmaceutical company posted revenue of $2,000 in the period.

Concert shares have fallen 35 percent since the beginning of the year. The stock has risen 16 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CNCE at https://www.zacks.com/ap/CNCE

Update hourly